Biogen Market Cap History



Below is a table of the Biogen market cap history going back to 2/5/2010:

Date BIIB Market Cap
2/5/201014.43B
4/16/201014.32B
7/16/201012.55B
10/22/201014.00B
1/31/201115.77B
4/18/201119.96B
7/22/201125.60B
10/25/201125.96B
1/31/201228.16B
4/24/201230.60B
7/18/201234.26B
10/19/201234.46B
1/31/201336.88B
4/18/201347.16B
7/18/201353.03B
10/21/201357.42B
1/31/201473.91B
4/18/201468.92B
7/18/201471.81B
10/17/201472.43B
1/30/201591.30B
3/23/2015108.80B
4/17/201598.66B
7/17/201595.16B
10/16/201560.71B
1/29/201659.71B
4/15/201658.82B
7/15/201657.04B
10/21/201663.24B
1/27/201760.08B
4/21/201757.89B
7/21/201759.82B
10/20/201771.50B
1/26/201877.84B
4/20/201855.50B
7/20/201872.26B
10/19/201864.56B
2/1/201965.09B
4/19/201943.90B
7/19/201942.66B
10/21/201940.33B
2/4/202049.31B
4/22/202048.63B
7/21/202044.36B
10/20/202041.10B
2/2/202142.31B
4/21/202140.63B
7/21/202148.13B
10/19/202139.39B
2/2/202233.06B
5/2/202230.36B
7/19/202231.96B
10/24/202239.55B
2/14/202341.77B
4/24/202342.41B
7/24/202340.12B
11/7/202335.59B
2/12/202435.58B

Also see: BIIB Shares Outstanding History
and BIIB YTD Return
Biogen Historical Market Cap:
+6.64% CAGR
Biogen Historical Market Cap: +6.64% CAGR

Mouse over chart for data details
2/5/2010 ...2/12/2024
Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Co. has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Co. also commercialize biosimilars of biologics and focuses on improving its pipeline in neuroscience and immunology. Co.'s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis. We show 58 historical shares outstanding datapoints in our BIIB shares outstanding history coverage, used to compute BIIB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing Biogen market cap history over the course of time is important for investors interested in comparing Biogen's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of Biogen versus a peer is one thing; comparing Biogen market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like Biogen can fluctuate over the course of history. With this page we aim to empower investors researching Biogen by allowing them to research the Biogen market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BIIB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biogen (BIIB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BIMI Market Cap History
BIO Market Cap History
BIOC Market Cap History
BIOL Market Cap History
BIOR Market Cap History
BIOS Market Cap History
BIVI Market Cap History
BJDX Market Cap History
BKD Market Cap History
BLCM Market Cap History
More Healthcare companies »

 

Biogen Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.